Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study. - Kao CM; Shih PC; Chen DY; Chen HH (Therapeutic advances in musculoskeletal disease, 2026)